COMPARISON OF DEFERASIROX, DEFERIPRONE, AND DESFERRIOXAMINE EFFECTIVENESS ON MYOCARDIAL IRON CONCENTRATIONS AND BIVENTRICULAR FUNCTION BY QUANTITATIVE MR IN BETA-THALASSEMIA MAJOR

被引：0
|
作者：
Pepe, A. [1 ]
Ramazzotti, A. [1 ]
Cianciulli, P. [2 ]
Spasiano, A. [3 ]
Capra, M. [4 ]
Borgna-Pignatti, C. [5 ]
Putti, M. C. [6 ]
Lippi, A. [7 ]
Romeo, M. A. [8 ]
Bisconte, M. G. [9 ]
Filosa, A. [10 ]
Caruso, V. [11 ]
Quarta, A. [12 ]
Pitrolo, L. [13 ]
De Sanctis, V. [14 ]
Gerardi, C. [15 ]
Maggio, A. [16 ]
Pietrangelo, A. [17 ]
Rossi, G. [1 ]
Lombardi, M. [1 ]
机构：
[1] CNR, Inst Clin Physiol, I-56100 Pisa, Italy
[2] St Eugenio Hosp, Ctr Talassemie, Rome, Italy
[3] Cardarelli Hosp, Ctr Cura Microcitemie, Naples, Italy
[4] G Di Cristina Hosp Arnas, Palermo, Italy
[5] Univ Ferrara, Dept Pediat, I-44100 Ferrara, Italy
[6] Univ Padua, Dept Pediat, Padua, Italy
[7] Meyer Hosp, Ctr Talassemie & Emoglobinopatie, Florence, Italy
[8] Univ Catania, Dept Pediat, Catania, Italy
[9] UO Ematol, Ctr Microcitemia, Cosenza, Italy
[10] Cardarelli Hosp, UOC Pediat, Naples, Italy
[11] Garibaldi Hosp, Ctr Microcitemia, Catania, Italy
[12] A Perrino Hosp, Brindisi, Italy
[13] Villa Sofia CTO Hosp, Palermo, Italy
[14] St Anna Hosp, Pediat Adolescent Unit, Dept Reprod & Growth, Ferrara, Italy
[15] Osped Civile, Ctr Talassemia, Sciacca, Agri Cento, Italy
[16] V Cervello Hosp, Palermo, Italy
[17] Univ Hosp Modena & Reggio Emilia, Ctr Hemochromatosis, Modena Reggio Emilia, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0901
引用
收藏
页码：358 / 358
页数：1
相关论文
共 50 条
  • [21] Comparison Of Two Combination Iron Chelation Regimens, Deferiprone and Deferasirox Versus Deferiprone and Deferoxamine, In Pediatric Patients With β-Thalassemia Major
    Elalfy, Mohsen Saleh
    Wali, Yasser
    Tony, S.
    Samir, Ahmed
    Adly, Amira
    BLOOD, 2013, 122 (21)
  • [22] A T2*MRI PROSPECTIVE SURVEY ON HEART AND LIVER IRON IN THALASSEMIA MAJOR PATIENTS TREATED WITH DEFERASIROX, DEFERIPRONE AND DESFERRIOXAMINE
    Pepe, A.
    Rossi, G.
    Meloni, A.
    Dell'Amico, M. C.
    Spasiano, A.
    Capra, M.
    Cianciulli, P.
    Caruso, V.
    Favilli, B.
    Cracolici, E.
    Lombardi, M.
    Maggio, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 426 - 426
  • [23] Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis
    Pennell, DJ
    Berdoukas, V
    Karagiorga, M
    Ladis, V
    Piga, A
    Aessopos, A
    Gotsis, ED
    Tanner, MA
    Smith, GC
    Westwood, MA
    Wonke, B
    Galanello, R
    BLOOD, 2006, 107 (09) : 3738 - 3744
  • [24] Lactation in beta-thalassemia major: is deferasirox compatible? The first case with clinical data and breastmilk concentrations
    Giampreti, Andrea
    Mattioli, Francesca
    Faraoni, Lorella
    Bedussi, Francesca
    Spada, Caterina
    Gallo, Mariapina
    Eleftheriou, Georgios
    Butera, Raffaella
    Bacis, Giuseppe
    CLINICAL TOXICOLOGY, 2018, 56 (06) : 539 - 539
  • [25] Bone marrow changes in beta-thalassemia major: quantitative MR imaging findings and correlation with iron stores
    Drakonaki, Eleni E.
    Maris, Thomas G.
    Papadakis, Alex
    Karantanas, Apostolos H.
    EUROPEAN RADIOLOGY, 2007, 17 (08) : 2079 - 2087
  • [26] Bone marrow changes in beta-thalassemia major: quantitative MR imaging findings and correlation with iron stores
    Eleni E. Drakonaki
    Thomas G. Maris
    Alex Papadakis
    Apostolos H. Karantanas
    European Radiology, 2007, 17 : 2079 - 2087
  • [27] A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
    Pepe A.
    Meloni A.
    Rossi G.
    Dell'Amico M.C.
    Spasiano A.
    Capra M.
    Cianciulli P.
    Caruso V.
    Favilli B.
    Cracolici E.
    Maggio A.
    Lombardi M.
    Journal of Cardiovascular Magnetic Resonance, 13 (Suppl 1)
  • [28] A T2*MRI Prospective Survey on Heart and Liver Iron In Thalassemia Major Patients Treated with Deferasirox Versus Deferiprone and Desferrioxamine In Monotherapy
    Pepe, Alessia
    Rossi, Giuseppe
    Meloni, Antonella
    Dell'Amico, Maria Chiara
    Spasiano, Anna
    Capra, Marcello
    Cianciulli, Paolo
    Caruso, Vincenzo
    Favilli, Brunella
    Cracolici, Eliana
    Lombardi, Massimo
    Maggio, Aurelio
    BLOOD, 2010, 116 (21) : 1731 - 1732
  • [29] Experience with Combination Therapy of Deferiprone and Desferrioxamine in beta-Thalassemia Major Patients with Iron Overload at Maternity and Children Hospital, Al Madinah Al Munawarah, Saudi Arabia
    Al Hawsawi, Zakaria Mohammad
    Sairafy, Mona Hamza
    Tarawah, Ahmed Mohamed
    Zolaly, Mohammed Adnan
    Al Hegaily, Abdul Rahman Soad
    JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2010, 5 (01): : 27 - 35
  • [30] Comparison of Magnetic Resonance Imaging T2 Results in Beta-Thalassemia Patients Treated by Deferasirox or Combination of Deferoxamine and Deferiprone
    Mirbehbahani, Nargesbeigom
    Vaseghi, Ghazal
    Rashidbaghan, Azam
    Vakili, Mohammad Ali
    Jahazi, Azam
    IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2020, 10 (04) : 241 - 249
12345